Roeker LE, Han Y, Teschemaker A, Mato AR, et al. BTK Inhibitors Versus Venetoclax as First- or Second-Line Therapy in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Real-World Evidence Study. Am J Hematol 2025 Feb 17. doi: 10.1002/ajh.27639.
PMID: 39960132